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The agglutination  of human erythrocytes of blood groups A, B, and O by 
Type XIV antipneumococcal horse  sera  has  been  clearly  demonstrated  (1, 
2).  Purified blood group A  substance from  commercial pepsin precipitates 
with Type XIV horse antiserum (3) and in one instance, removed about one- 
half of the antibody from an antiserum.  In addition, both the specific polysac- 
charide of the Type XIV pneumococcus (SXIV) and, after partial hydrolysis, 
the  blood group  A  substance  react  with  horse  antianthrax  sera  (4).  The 
chemical basis for these cross-reactions has been clarified  by the finding that 
the blood group A substance, SXIV, and the C polysaccharide of the anthrax 
bacillus contain in common N-acetyl glucosamine and galactose (3, 4).  With 
the demonstration  that  purified  blood group A  and  O  substances from  in- 
dividual hog stomach linings were identical in a considerable number of chemical 
and physical properties  ($) and that both contained N-acetyl d-gtucosamine, 
d-galactose, and/-fucose (6) it was considered that a quantitative study of the 
precipitin  reaction  of  these  substances  with  Type XIV  antipneumococcal 
horse serum might provide information about their structural similarities and 
differences.  The surprising result was that preparations of hogblood group A 
substance differed widely in their capacity to precipitate anti-SXIV although 
they were all of equal purity and had the same capacity to precipitate homol- 
ogous anti-A  formed in man  ($).  Similar  variations  in  precipitability for 
anti-SXIV  were found  among  various  preparations  of hog  blood group  O 
substance, and of blood group A  and O substances from human  saliva and 
stomach (7). 
EXPERIMENTAL 
The blood group A and 0 substances from individual hog stomach linings and the blood 
group A  substances from human saliva, stomach, and amuiotic fluid were  the preparations 
* The work described in this paper was carried out under a  grant-in-aid from  the United 
States Public Health service and in part under the William J. Matheson Commission. 
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that had been used in previous studies (5-7).  In addition, samples of blood group substances 
were purified from human B and O saliva  and another preparation of O substance was obtained 
from a human stomach by the method described for the isolation of the blood group A sub- 
stance (7). 
Two Type XIV antipneumococeal horse sera were used; A66, supplied by Dr. A. J. Well of 
Lederle Laboratories contained both Type XIV and Type XIX antibody, and H635  (1939 
bleeding)  provided by the New York State Department of Health Laboratories.  The two 
sara contained 1.08 and 0.87 rag. anti-SXIV N  per ml. and both sara agglutinated human 
erythrocytes of blood groups A, B, and O. 
The cross-reaction between the various blood group substances was studied by adding in- 
creasing quantities of blood group substance dissolved in saline to a series of i0 ml. conical 
centrifuge tubes each containing a measured volume of antiserum at 0°C.; the total volume 
was kept constant.  The contents of the tubes were mixed and the tubes kept in the re- 
frigerator for a week  (8) during which period their contents were mixed twice daffy.  The 
precipitates were then centrifuged off in a refrigerated centrifuge,  washed twice in the cold 
with chiUed saline, quantitatively transferred to 10 ml. micro-Kjeldahl  flasks with water and 
a few drops of xr/2 NaOH, and analyzed for nitrogen by the Markham micro-Kjeldahl  method 
(9).  Values represent the average of duplicate analyses.  Supernatants from each pair of 
analyses were  combined and divided in half.  To one portion 25 or 50 pg. blood group sub- 
stance was added to test for residual cross-reacting antibody and to the other portion 0.1 ml. 
of antiserum was added to test for excess blood group substance.  Supematant tests were set 
up at 0°C., left in the refrigerator for 1 week, centrifuged in the cold, and the degree of precipi- 
tation in each tube was noted. 
R~ESULTS 
From Table I  it is evident that individual preparations of hog blood group 
A  substance  vary  greatly  in  their  capacity  to  precipitate with  Type  XIV 
antipneumococcal horse  sera.  For  instance,  500  pg.  of  the  blood group  A 
substance from hog  10 precipitated only 19/~g.  N  from 0.5  ml.  serum  t-I635 
while equal amounts  of similar products from hogs  16,  3,  and 8  precipitated 
39, 72, and 72 ~g. N  respectively.  The same range of variation in precipitating 
power was also observed with hog blood group O substances.  Tests on super- 
natants were carried out in all instances and invariably showed a  broad zone 
of precipitation indicating the presence of both antigen and antibody.  Several 
representative sets of supernatant tests are shown in Table I.  From the data 
with hog 16 and hog 29, it is evident that 1 week in the refrigerator was adequate 
for  maximum  precipitation.  With  material  from  hog  29,  no  difference  in 
capacity to precipitate Type XIV antibody was found after the solution had 
remained in the refrigerator for 6 weeks. 
The same type of variation in capacity to precipitate with Type XIV anti- 
serum  was  observed with  blood group  A  substance  from  human  saliva and 
stomach  (Table II) as well as with materials prepared by  the same methods 
from O  saliva and stomach.  Data are included on the relative viscosity and 
on the capacity of the various samples to precipitate anti-hog A formed in man 
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the same capacity to precipitate anti-A but that from stomach 2 was about 
twice as potent in precipitating antibody from Type XIV antipneumococcal 
serum,  Similarly,  the products from B. K. precipitated considerably more 
antibody in the cross-reaction than did A. B.4 or W. H.110 per cent precipitates 
TABLE I 
Cross-Reaction of Purified Blood Group A  and 0  Substances  from Individual  Hog Stomach Linings 
ugth Type XIV Antipneumococcal Horse Scra 
Total nitrogen precipitated 
Amount  Blood group A substances  I  Blood group 0  substances 
added  --  Hog  --Hog-  Hog  Hog  Hog  Hog 
Hog 3 Hog 8  +  +  10  +  +  15  13  19  25  27 
,taog e  body  10  body 
O.5 mL//63f 
100  22  32  $  ++  ++  13  18  15  27  20  8  33  28  29  25 
150  31  42  -l--l-  +  13  -t--~  ']-+  17  19  39  14  46  35  36  $1 
250  46  54  --}-+  16  +-}-  +-{-  23  25  43  18  64  44  $9 
..q)0  72  +.4-  +.4-  19  ++  -l--l"  35  39  38  54  23  80  63  60 
0.$ raL A66 
50 
100 
150 
2OO 
3OO 
400 
$OO 
tel.§  (5)...  1.65 
19  ++++ 
25  +++.4- 
28  +++ 
33  +++ 
+++ 
1.39 
--{-  16 
++±  20 
++-l-  20 
-}-+-[-  21 
++4- 
17 
18 
1.71 
++  + 
+-l-  +:e 
+  +=e 
+±  ++ 
+±  ++ 
1.64  1.58  1.58 
17  31 
24  48 
31  54 
32  77 
37  73 
43  96 
1.27  1.56  1.40 
"Set (b) was identical with set (a) but tubes were allowed to remain in the refrigerator  for 2 weeks instead of 1 week. 
$ Sets (b) and (c) run 6 weeks after set (a), set (c) was washed and analyzed after 2 weeks in the refrigerator.  Fresh 
solution used for set (a). 
§ Relative viscosity of 0.2 per cent solution in 0.9 per cent eallne. 
(7)  although they showed  only about one-half the potency in precipitating 
anti-A. 
The preparations from amnlotic fluid and from human stomach 1  were 
unusually potent in precipitating with Type XIV antiserum although they 
showed only 17 per cent of the capacity of other samples in precipitating anti-A. 
Blood group B substance from human saliva also precipitated with Type XIV 
antiserum, essentially similar data being  obtained with the phenol-insoluble 
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TABLE II 
Cross-Reaction  of Purified Blood Group Substances from Human Sources v~ith Type XIV 
Anlipneumococcal Horse Sera 
Amount 
substance 
added 
Total nitrogen precipitated 
Human saliva 
A substance 
G.C.  W.H.____  t 
lO% "~.~ to% "~.~ lo% 
ppt  ~  ppt  ~  ppt 
W, H.2 
2~ 
B sub-  st~ 
stance  I' i 
B.K.  M..  W.[  S  E  IF. 
..~  .~  lo%to% 
~ Ippt]  ~  ~  l-;  Ipptq  ppt" 
0.~ ml. H635 
20  29  29  47  38  31  47  16  70  37  33  16  22  45  100  30  26  30  23  32 
4~  28  46  41  61  46  36  62  25  86  45  38  18  27  56  39  29  150  36  39 
250  50  50  43  40  60  63  60  74  61  42  46  86  29  108  52  46  23  39  72 
500  61  60  81  55  58  102  86  88  56  65  42  125  65  62  29  ,50 
0.5 ml. A66 
I Amni-fluid I  i  otic  I  Hmnan stomach 
i 
A sub-  -  -  -  .6  nee 
ivan  0  stance  A suoscance  ~ 
Phenol.-  I0~  insol- 
50  17  I  14  9  27 
100  25  ]  17  14  43 
150  36 I  20  16  51 
250  [  26  24  63 
500  37  33  88 
I 
Relative  ]  I  I  ] 
'~Pacltyl  /  I 
cipltate  /  ]  ] 
anti'A  1  ]  l 
c. ...... i  /   o; oo,  ,o  :7  . oo oo 
DISCUSSION 
The  data  presented  confirm  previous  observations  (3)  that  purified  hog 
blood group A substances precipitate with Type XIV antipneumococca] horse 
serum and in addition establish that hog blood group O  substances and human 
blood group substances from individuals of groups A,  B,  and O  also  cross- 
react with Type XIV antipneumococcal antibody.  Since these purified prep- 
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XIV specific polysaccharide,  N-acetyl-d-glucosamine  and galactose,  it seems 
reasonable to attribute the cross-reactivity to this similarity in chemical com- 
position and thereby to provide a reasonable  explanation for the capacity of 
Type XIV  antiserum to agglutinate human erythrocytes of all four blood 
groups.  Preparations of the various blood group substances also inhibit the 
agglutination of human A, B, or O erythrocytes by the Type XIV antiserum. 
The broad zones over which supernatants from the reaction of the blood 
group  substances  with  Type XIV  horse  antiserum  invariably showed  the 
presence  of both antigen and antibody are also best interpreted on the basis 
of a cross-reaction similar to that between Types III and VIII antipenumococ- 
cal horse antibodies and their heterologous  specific polysaccharides  (10, ll). 
Individual preparations of purified  hog blood group A  substances,  all of 
which were  shown  by quantitative immunochemical assays to  be  of equal 
potency in their reactivity with anti-hog A formed in man (5), vary widely in 
their cross-reactivity with Type XIV antipneumococcal antibody (Table I). 
Similar  variations apparently unrelated to the capacity of the substance to 
precipitate anti-A were also found for the human A substances from saliva and 
stomach (7).  Whether the differences in the cross-reactivity of the various 
O substances from hog stomachs and of materials of similar composition from 
human group O saliva are also unrelated to their potency as group O sub- 
stances cannot yet be decided since quantitative precipitin assays for anti-O 
are not available and assays by inhibition of hemagglutination are not suf- 
ficiently precise to provide a definitive answer.  The differences in cross-reac- 
tivity among the individual A or O preparations could not be correlated with 
the relative viscosity of their solutions, and do not appear to be due to technical 
difficulties  such  as  failure to attain maximum precipitation since  identical 
results were obtained when precipitin analyses were (hogs 16 and 29, Table I) 
carried out after the tubes had been in the refrigerator for 2 weeks instead of 
1 week; in addition no detectable change in precipitating capacity of the sub- 
stance from hog 29 occurred  after the solution had remained 6 weeks in the 
refrigerator. 
It is not possible at present to offer an adequate explanation of these find- 
ings.  However,  it has previously been established by quantitative precipitin 
assays that solutions of hog blood group A substance are extraordinarily stable 
with regard to their blood group A activity, no detectable reduction in potency 
occurring after exposure for 2 hours at 100°C. in solutions varying in pH from 
2.97 to 7.58 (12).  That such individual preparations may vary in their cross- 
reactivity with Type XIV antipneumococcal  serum and not in their blood group 
A activity suggests that the two activities may be associated with different por- 
tions of the  complex  molecule  and  that it may be possible  under suitable 
conditions to alter one without affecting the other.  It is apparent that any 300  ll#~U~0¢H):MICA]~  STUDI~S  ON BLOOD  GROUPS.  VI 
adequate explanation of the chemical basis for the unique biological  activities 
of the blood group substances must account for the differences herein noted. 
SUMMARY 
Purified blood group A, B, and 0  substances from hog and human sources 
precipitate  with  Type XIV antipneumococcal  horse serum  and provide an 
explanation for the observation that Type XIV antibody agglutinates human 
erythrocytes of all four major blood groups. 
Individual preparations  of A substance or 0  substance from either species 
vary in their capacity to precipitate Type XIV antibody although the hog A 
substances did not differ in potency toward anti-A.  Similarly,  no correlation 
between A activity and reactivity with Type XIV antibody could be found 
among the human A substances. 
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